Full-Time

Senior Scientist

Machine Learning

Confirmed live in the last 24 hours

Generate Biomedicines

Generate Biomedicines

201-500 employees

Generates novel medicines using generative biology

AI & Machine Learning
Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Applied Machine Learning
AI Research
AI & Machine Learning
Required Skills
Python
R
Pytorch
NumPy
Requirements
  • PhD in Computational Biology, Computer Science, or a related field with a track record of innovative ML method development for scientific applications
  • Experience developing ML methods to solve scientific problems, with a particular interest towards applications to protein modeling as well as adjacent fields such as genomics, chemistry, immunology, or physics
  • Experience developing, debugging, and scaling models using modern deep learning frameworks such as Pytorch or JAX
  • Proficiency in Python and experience analyzing data with Numpy/Scipy, R, or similar
  • Foundational knowledge of probabilistic ML and inference methods
  • Practical experience with developing deep generative models (e.g., language models, diffusion models, EBMs, VAEs, flows, etc.)
  • Domain expertise around protein design, biochemistry, genetics, biophysics, and/or chemistry as well as practical experience working with data in these domains
  • Publications at major scientific venues such as ML conferences or scientific journals that apply ML to advance problems in molecular biology, structural biology, or genetics, especially at the intersection of ML and proteins
  • Demonstrated experience developing software in a team setting
  • Experience with optimizing performant code
Responsibilities
  • Develop foundational generative models and algorithms for designing and reasoning about the sequences, structures, and functions of proteins
  • Scale systems with our extensive GPU resources to maximally leverage protein and biological data, combining all that can be learned from evolution, the scientific literature, and active data acquisition in our proprietary, in-house high throughput assays and Cryo-EM platform
  • Collaborate with wet lab and platform technology teams groups to unlock high-impact therapeutic applications and design novel proteins across diverse therapeutic modalities
  • Engineer production-grade machine learning systems in conjunction with our Engineering teams for large-scale distributed compute setups and be deployed for design of million-variant+ de novo libraries
  • Present in regular research meetings and prepare materials for broader internal and external communication across disciplines
  • See your generative models produce real proteins that are built, characterized, and on a path to be life-changing therapies
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. This approach involves analyzing millions of proteins to learn how nature encodes their functions, allowing the company to design medicines with specific therapeutic effects. The main product, The Generate Platform, enables the rapid production of medicines across various therapeutic areas, significantly improving the drug discovery process compared to traditional methods. Unlike its competitors, Generate Biomedicines emphasizes a proactive and efficient approach to medicine creation, aiming to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating novel medicines, having already produced and tested 42,000 proteins.

Company Stage

Series C

Total Funding

$674.1M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

11%

2 year growth

37%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $273M Series C financing round provides substantial capital to advance their generative AI pipeline and clinical programs.
  • Expansion of the leadership team with experienced professionals like Rupert Vessey, Nancy Simonian, and Kym White strengthens the company's strategic direction and operational capabilities.
  • Publication of the Chroma model in Nature highlights the company's innovative contributions to protein therapeutics, enhancing its reputation in the scientific community.

What critics are saying

  • The reliance on cutting-edge generative AI and machine learning technologies may face regulatory and adoption challenges in the conservative pharmaceutical industry.
  • Rapid expansion and scaling efforts, including new hires and leadership changes, could lead to integration and cultural challenges.

What makes Generate Biomedicines unique

  • Generate Biomedicines leverages generative biology and machine learning to create medicines on demand, a significant departure from traditional drug discovery methods.
  • The Generate Platform's ability to produce novel medicines across multiple therapeutic areas with high speed and success rates sets it apart from competitors.
  • Their focus on understanding the rules by which nature encodes function to design new proteins is a unique approach in the biotechnology sector.

Help us improve and share your feedback! Did you find this helpful?